Cancer cells exhibit metabolic reprogramming due to genetic mutations and alterations in signaling pathways. These changes can lead to the upregulation of enzymes and transporters that facilitate increased glucose uptake and lactate production. Additionally, oncogenes and tumor suppressor genes play a crucial role in orchestrating these metabolic shifts to support rapid cell division and survival.
